Serum lipids concentration on prognosis of high-grade glioma

被引:2
作者
Huang, Fei [1 ,3 ,4 ,5 ]
Li, Shan [2 ,4 ,5 ]
Wang, Xuezhen [2 ]
Wang, Caihong [2 ]
Pan, Xiaoxian [2 ]
Chen, Xiuying [2 ,4 ,5 ]
Zhang, Weijian [2 ,4 ,5 ]
Hong, Jinsheng [2 ,4 ,5 ]
机构
[1] Fujian Med Univ, Affiliated Hosp 1, Cent Lab, 20 Chazhong Rd, Fuzhou 350005, Fujian, Peoples R China
[2] Fujian Med Univ, Canc Ctr, Dept Radiotherapy, Affiliated Hosp 1, 20 Chazhong Rd, Fuzhou 350005, Fujian, Peoples R China
[3] Fujian Med Univ, Affiliated Hosp 1, Cent Lab, Natl Reg Med Ctr, Binhai Campus, Fuzhou 350212, Fujian, Peoples R China
[4] Fujian Med Univ, Affiliated Hosp 1, Fujian Higher Educ Inst, Key Lab Radiat Biol, 20 Chazhong Rd, Fuzhou 350005, Fujian, Peoples R China
[5] Fujian Med Univ, Fujian Prov Key Lab Precis Med Canc, 20 Chazhong Rd, Fuzhou 350005, Fujian, Peoples R China
关键词
Cholesterol; LDL; HDL; Glioma; High-grade; Prognosis; TUMOR-TREATING FIELDS; CHOLESTEROL; GLIOBLASTOMA; IDH; SURVIVAL; THERAPY; DIET; TERT; LDL; HDL;
D O I
10.1007/s10552-023-01710-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective To investigate the effect of serum lipids concentration on the prognosis of high-grade glioma patients undergoing postoperative radiotherapy. Methods Retrospective analysis of the patients with high-grade glioma who received postoperative Intensity Modulated Radiotherapy between 13 May 2013 and 12 September 2018 was performed. The patients were grouped according to the average values of serum total cholesterol, LDL, and HDL concentration in peripheral blood (before surgery, 6 months after therapy). Cox proportional hazards model was performed to determine whether the total cholesterol concentration, LDL concentration, and HDL concentration in peripheral blood before therapy and their changes after therapy were factors influencing the prognosis. Results The results of COX regression analysis showed that the independent prognostic factors of high-grade glioma patients were pathological grade, the extent of resection, serum cholesterol concentration pre-surgery, and the change of LDL concentration from pre-surgery to post-therapy. The prognosis of patients with high serum total cholesterol concentration before therapy was worse than those of patients with low total cholesterol concentration. The 5-year survival rate and the median survival time of patients with high serum total cholesterol concentration before therapy were 4.9% and 23.6 months, but the low cholesterol concentration group were 19.6% and 24.5 months, respectively. Besides, the average serum LDL concentration in high-grade glioma patients gradually increased after therapy. The 5-year survival rate of patients and the median survival time with elevated LDL concentration after therapy is 11.8% and 20.4 months, but the reduced LDL concentration group was 16.7% and 28.4 months, respectively. The total cholesterol and LDL concentration increased significantly after therapy in Grade IV patients while Grade III patients did not. Conclusions The cholesterol concentration before therapy and LDL concentration change from pre-surgery to post-therapy are the factors that affect the prognosis of high-grade glioma patients who have undergone postoperative radiotherapy. In the final analysis, the high serum cholesterol pre-surgery and the increased in serum LDL concentration from pre-surgery to post-therapy were associated with worse survival of patients.
引用
收藏
页码:801 / 811
页数:11
相关论文
共 40 条
  • [1] Glioblastoma multiforme: a review of where we have been and where we are going
    Adamson, Cory
    Kanu, Okezie O.
    Mehta, Ankit I.
    Di, Chunhui
    Lin, Ningjing
    Mattox, Austin K.
    Bigner, Darell D.
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (08) : 1061 - 1083
  • [2] Adult Glioblastoma
    Alexander, Brian M.
    Cloughesy, Timothy F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (21) : 2402 - +
  • [3] Acyl-coenzyme A Cholesterol acyltransferase inhibitor Avasimibe affect survival and proliferation of glioma tumor cell lines
    Bemlih, Sana
    Poirier, Marie-Denise
    El Andaloussi, Abdeljabar
    [J]. CANCER BIOLOGY & THERAPY, 2010, 9 (12) : 1025 - 1032
  • [4] The Evolving Role of Tumor Treating Fields in Managing Glioblastoma Guide for Oncologists
    Burri, Stuart H.
    Gondi, Vinai
    Brown, Paul D.
    Mehta, Minesh P.
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (02): : 191 - 196
  • [5] Combined analysis of TERT, EGFR, and IDH status defines distinct prognostic glioblastoma classes
    Chamberlain, Marc C.
    Sanson, Marc
    [J]. NEUROLOGY, 2015, 84 (19) : 2007 - 2007
  • [6] Diet and risk of adult glioma in eastern Nebraska, United States
    Chen, HL
    Ward, MH
    Tucker, KL
    Graubard, BI
    McComb, RD
    Potischman, NA
    Weisenburger, DD
    Heineman, EF
    [J]. CANCER CAUSES & CONTROL, 2002, 13 (07) : 647 - 655
  • [7] Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
    Cloughesy, Timothy F.
    Mochizuki, Aaron Y.
    Orpilla, Joey R.
    Hugo, Willy
    Lee, Alexander H.
    Davidson, Tom B.
    Wang, Anthony C.
    Ellingson, Benjamin M.
    Rytlewski, Julie A.
    Sanders, Catherine M.
    Kawaguchi, Eric S.
    Du, Lin
    Li, Gang
    Yong, William H.
    Gaffey, Sarah C.
    Cohen, Adam L.
    Mellinghoff, Ingo K.
    Lee, Eudocia Q.
    Reardon, David A.
    O'Brien, Barbara J.
    Butowski, Nicholas A.
    Nghiemphu, Phioanh L.
    Clarke, Jennifer L.
    Arrillaga-Romany, Isabel C.
    Colman, Howard
    Kaley, Thomas J.
    De Groot, John F.
    Liau, Linda M.
    Wen, Patrick Y.
    Prins, Robert M.
    [J]. NATURE MEDICINE, 2019, 25 (03) : 477 - +
  • [8] Circulating lipids and glioma risk: results from the UK Biobank, Nurses' Health Study, and Health Professionals Follow-Up Study
    Cote, David J.
    Smith-Warner, Stephanie A.
    Creed, Jordan H.
    Furtado, Jeremy
    Gerke, Travis
    Wang, Molin
    Kim, Youngchul
    Stampfer, Meir J.
    Egan, Kathleen M.
    [J]. CANCER CAUSES & CONTROL, 2021, 32 (04) : 347 - 355
  • [9] Quercetin inhibition of SREBPs and ChREBP expression results in reduced cholesterol and fatty acid synthesis in C6 glioma cells
    Damiano, Fabrizio
    Giannotti, Laura
    Gnoni, Gabriele, V
    Siculella, Luisa
    Gnoni, Antonio
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2019, 117
  • [10] Re-irradiation alternatives for recurrent high-grade glioma
    Dong, Yuanli
    Fu, Chengrui
    Guan, Hui
    Zhang, Tianyi
    Zhang, Zicheng
    Zhou, Tao
    Li, Baosheng
    [J]. ONCOLOGY LETTERS, 2016, 12 (04) : 2261 - 2270